Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06509854

PAthwAy of Dyspneic patIent in Emergency in France

This observational retrospective multi-center study focuses on patients treated for acute dyspnea by emergency medical teams. The primary objective is to identify factors associated with the risk of mortality and rehospitalization in these patients. This evaluation will be conducted both overall and within specific subgroups of interest, including gender (men/women), age categories, mode of admission, and comorbidities.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Besançon, Besançon, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Man or women aged 18 years and older.
  • Patients with acute dyspnea managed by a medical emergency team at the investigator centers between 2010 and 2021.

Exclusion criteria

  • Cardiorespiratory arrest before emergency department management.

Treatment and study plan

Primary outcomes

  1. All-cause post-hospitalization mortality and rehospitalization

    Time frame: Within 5 years following hospital discharge

    Composite endpoint of all-cause post-hospitalization mortality and rehospitalization

Secondary outcomes

  1. Proportion of readmissions (all-cause and specific - including hospitalization for acute dyspnea ).

    Time frame: 1 month and 1 year post admission for acute dyspnea in the emergency department

  2. Post admission mortality

    Time frame: Within 20 years following hospital discharge

    Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term). with outcome 5.

  3. Post admission rehospitalization

    Time frame: Within 20 years following hospital discharge

    Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term) with outcome with outcome 4.

  4. Erroneous etiological diagnosis of dyspnea in the emergency department

    Time frame: Within hospital stay, maximum 21 days

    Assessed by: defined as a discrepancy between the diagnosis at discharge from the emergency department and the final diagnosis in the hospital discharge letter

  5. All-cause mortality and specific mortality (cardiovascular and non-cardiovascular).

    Time frame: Within 5 years following hospital discharge

    Assessed by: Composite endpoint of all-cause mortality and specific mortality (cardiovascular and non-cardiovascular) with outcome 8

  6. Emergency post-admission mortality

    Time frame: Within 20 years following hospital discharge

    Assessed by: Composite criterion of mortality and rehospitalization post-admission for acute dyspnea in the emergency department over the long term with outcome 9

  7. Emergency post-admission rehospitalisation

    Time frame: Within 20 years following hospital discharge

    Assessed by: Composite criterion of mortality and rehospitalization post-admission for acute dyspnea in the emergency department over the long term outcome 8

  8. Duration of stay in the emergency department

    Time frame: Within hospital stay, maximum 21 days

    Assessed by: Duration of stay in the emergency department

  9. Erroneous etiological diagnosis of dyspnea in the emergency department

    Time frame: Within hospital stay, maximum 21 days

    Assessed by: Erroneous etiological diagnosis of dyspnea in the emergency department

  10. In-hospital mortality

    Time frame: Within hospital stay, maximum 21 days

    Assessed by: In-hospital mortality

  11. Length of hospital stay

    Time frame: Within hospital stay, maximum 21 days

    Assessed by: Length of hospital stay

  12. Post emergency admission (For dyspnea) mortality and rehospitalization

    Time frame: Within 5 years following hospital discharge

    Assessed by: Post emergency admission (For dyspnea) mortality and rehospitalization

Study contacts

Contact information is provided by the study sponsor or research team.

Nicolas GIRERD, MD, PhD

CONTACT

[email protected]

+33383157322

Tahar CHOUIHED, MD, PhD

CONTACT

[email protected]

+33383157322

Sponsors and collaborators

Lead sponsor

Pr. Nicolas GIRERD

Other

Registry information

Acronym: Fr-PArADIse

Important dates

Study start
2024
Primary completion
2025
Study completion
2031
First posted
Jul 19, 2024
Registry last updated
Jul 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.